Medical Devices Investors & VC Firms in United States
516 firms in this list, with a median first check of $500K. 35 of them lead rounds. Generated from verified public data and updated continuously.
Serendipity Impact VC
New YorkSeed–Series B
5 people
TVM Capital
MunchenSeed–Late Stage$1.1M – $16.2M
8 people
VantagePoint Capital Partners
Santa BarbaraSeed–Late Stage$2M – $100M
8 people
Norwich Ventures
WalthamSeed–Series A
2 people
Cape Fear BioCapital
DurhamPre-Seed–Series B
3 people
MedMountain Ventures
Salt Lake CityPre-Seed–Series A
4 people
Boston Millennia Partners
BostonSeed–Late Stage$3M – $5M
7 people
Catalys Pacific
TokyoSeed–Series A
10 people
EcoR1 Capital
San FranciscoSeed–Late Stage
10 people
Pivotal Life Sciences
San FranciscoSeed–Late Stage
10 people
Sutter Hill Ventures
Palo AltoSeed–Late Stage$100K – $5M
3 people
Ecliptic Capital
AustinPre-Seed–Series B$50K – $5M
6 people
Dynamk Capital
New YorkSeed–Series B
3 people
Corner Ventures
New YorkSeed–Late Stage
8 people
LifeSci Venture Partners
New YorkSeries A–Late Stage
2 people
Abstract
West TiburonPre-Seed–Late Stage$250K – $750K
6 people
Ajax Health
Menlo ParkSeed–Late Stage
9 people
Altitude Ventures Management, Llc
KirklandPre-Seed–Seed
3 people
Amplitude Venture Capital
MontrealSeed–Late Stage
9 people
Angelini Ventures
RomeSeries A–Series B
9 people
Applied Ventures
Santa ClaraSeed–Late Stage$500K – $3M
6 people
BioAdvance
ConshohockenPre-Seed–Late Stage$250K – $1.5M
6 people
Bios Partners
Fort WorthSeed–Series B
9 people
Bioventures Investors
WestboroughSeed–Late Stage$3M – $10M
6 people
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.